Reported Oct 9, 2026 · Announced · Updated Oct 19, 2026
Par Health recalls Par Pharmaceutical Brevital Sodium 500 mg/vial for Injection due to Presence of particulate matter identified as cellulose
Par Health
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
What it looks like
Is this the product you have?
- Brevital
- Sodium 500 mg/vial for Injection BrandPar Pharmaceutical. Drugs
Why it was recalled
Presence of particulate matter identified as cellulose
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Par Health recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.